Madsen Julia 4

What Happened Julia Madsen, Senior Vice President and GM, Life Sciences at STERIS plc, received equity awards on June 2, 2026: 2,316 ordinary shares (awarded) and an 8,080-share derivative award (grant). On the same date 127 shares were withheld to satisfy tax withholding requirements; those shares were valued at $209.76 each for a total withholding value of $26,640. The 127 withheld shares were taken from 352 restricted shares that vested on June 2, 2026.

Key Details

• Transaction date: June 2, 2026 (Form 4 filed June 4, 2026 — appears timely).
• Grants: 2,316 ordinary shares @ $0.00 (award); 8,080 derivative shares @ $0.00 (award/option-type grant).
• Tax withholding: 127 shares disposed (F) at $209.76 each = $26,640; these were withheld from 352 vested restricted shares (F2).
• Restricted/vesting specifics (F1): as of June 2, 2026, 5,398 ordinary shares are restricted; portions lapse on scheduled dates between June 2026 and June 2029 (detailed schedule in filing).
• Option exercisability (F3): the derivative award becomes exercisable in four tranches of 2,020 shares in 2027, 2028, 2029 and 2030.
• Shares owned after the transaction: total post-transaction holdings not specified beyond the restricted-share counts in footnotes.
• Transaction codes: A = award/grant; F = tax withholding.

Context This filing reflects compensation-related awards and routine tax withholding, not an open-market sale or purchase. The 127-share disposal was used solely to meet tax obligations (common with vested restricted shares) and does not on its own signal a directional view of the stock. The 8,080-share derivative award is subject to future vesting/exercise schedules outlined in the filing.